KAYCE KRUCKI: Open Payments
NPI 1538670062 · COLUMBUS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,879 in 158 payments from 15 companies in 2025. Trend: 2023 $1,423 · 2024 $2,750 · 2025 $2,879
Food & beverage: $2,879
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 40 | $744 |
| Janssen Biotech, Inc. | 37 | $542 |
| Novartis Pharmaceuticals Corporation | 20 | $424 |
| Amgen Inc. | 25 | $375 |
| UCB, Inc. | 10 | $147 |
| ASAHI INTECC USA, INC. | 1 | $135 |
| Lilly USA, LLC | 4 | $95 |
| E.R. Squibb & Sons, L.L.C. | 4 | $89 |
| GlaxoSmithKline, LLC. | 4 | $64 |
| GENZYME CORPORATION | 3 | $61 |
Products named: RINVOQ, TREMFYA, COSENTYX, Bimzelx, Otezla, Asahi Peripheral Vascular Wires, KRYSTEXXA, SKYRIZI.
Industry payments across OH — which companies pay providers there.
